Surveying from Above: Building Your Tool Kit with Purpose

On “Track. Map. Measure.,” host Shaun MacIntosh is constructing a show with a host of thought-leaders from the industry that quite literally builds the world around us – construction.

 

Land surveying has advanced dramatically in recent years as new tech allows for greater accuracy. Today, there are many different devices used to map, all with their own pros and cons to gathering accurate data. On the inaugural episode of Track.Map.Measure, host Shaun MacIntosh welcomes Matt Gendron, Senior Account Executive at Propeller Aero, to discuss the various mapping apparatus and how they can work together.

Lidar, photogrammetry, drone mapping, rover, or just old-fashioned on the ground mapping; there is more than one way to collect land data. MacIntosh elaborates on Lidar, light detection and ranging, and where it excels. Found in Tesla cars and perfect for indoor mapping, Lidar still has a long way to go to be consumer-friendly, but its accuracy is unparalleled. Gendron dives into drone photogrammetry, that is, camera-based surveys. Gendron said he still sees photogrammetry used 95% of the time on-site, due in part to its ease of use, affordability, and approachable learning curve. But perhaps most important in surveying is knowing which tool will best suit your purpose, be it surveying a highly-vegetated site, or an interior warehouse.

Gendron and MacIntosh break down use case scenarios and why you can never have enough data on Track.Map.Measure.

Stay Tuned For New Episodes Every Other Wednesday!

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More